MBX Biosciences

MBX

Insider trades and stock quote 2024-2026

All insider trades at MBX Biosciences

Subscribe RSS
Date Type Insider Position Ø-Price Volume
8/4/2026 Sell Azoulay, Salomon Chief Medical Officer $65.8 $24,335
5/8/2026 Sell Azoulay, Salomon Chief Medical Officer $38.3 $2,685,515
5/6/2026 Sell Hawryluk, P. Kent President & CEO $29.5 $17,931
5/6/2026 Sell Azoulay, Salomon Chief Medical Officer $29.5 $6,824
3/13/2026 Buy Hawryluk, P. Kent President & CEO $28.4 $525,663
10/20/2025 Buy Hawryluk, P. Kent President & CEO $13.6 $272,790
10/17/2025 Buy Hoerter, Steven L. Director $13.2 $264,984
9/26/2025 Buy Heron, Patrick J. Director $18.0 $11,999,988
4/8/2025 Buy Pescovitz, Ora H. Director $5.9 $45,312
2/18/2025 Buy Orbimed Advisors LLC Director $10.8 $1,551,963
2/18/2025 Buy Gordon, Carl L. Director $10.8 $1,551,963
2/14/2025 Buy Orbimed Advisors LLC Director $9.9 $468,793
2/14/2025 Buy Gordon, Carl L. Director $9.9 $468,793
2/4/2025 Buy Hawryluk, P. Kent President & CEO $10.7 $534,500
9/16/2024 Buy Gordon, Carl L. Director $16.0 $12,000,000
9/16/2024 Buy Aynechi, Tiba Director $16.0 $12,000,000
9/16/2024 Buy Heron, Patrick J. Director $16.0 $10,000,000
9/16/2024 Buy Frazier Life Sciences X, L.p. Ten Percent Owner $16.0 $10,000,000
9/16/2024 Buy New Enterprise Associates 17, L.p. Ten Percent Owner $16.0 $8,000,000
9/16/2024 Buy Orbimed Advisors LLC Director $16.0 $12,000,000
9/16/2024 Buy Sandell, Scott D. Ten Percent Owner $16.0 $8,000,000
9/16/2024 Buy Yang, Rick Ten Percent Owner $16.0 $8,000,000
9/16/2024 Buy Walker, Paul Edward Ten Percent Owner $16.0 $8,000,000
9/16/2024 Buy Makhzoumi, Mohamad Ten Percent Owner $16.0 $8,000,000
9/16/2024 Buy Florence, Anthony A. Jr. Ten Percent Owner $16.0 $8,000,000
9/16/2024 Buy Chang, Carmen Ten Percent Owner $16.0 $8,000,000
9/16/2024 Buy Behbahani, Ali Ten Percent Owner $16.0 $8,000,000
9/16/2024 Buy Baskett, Forest Ten Percent Owner $16.0 $8,000,000
9/16/2024 Buy Mathers, Edward T. Director $16.0 $8,000,000
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)